Researchers from Wistar Institute, USA, have discovered a new class of antibiotics that can kill pan drug-resistant bacteria and stimulate a rapid immune response. The drugs can help in combatting antimicrobial resistance. These findings have been published in the journal Nature. Antimicrobial resistance (AMR) is a rising global health burden.
According to the WHO, AMR is one of the top ten global public health threats, as previously curable infectious diseases may become untreatable and spread worldwide due to AMR. New advances in drug development such as rapid processes, availability of sources, and artificial intelligence can help design and develop new drugs to tackle AMR. The new antibiotics developed by scientists at Wistar Institute, USA, using the double-pronged strategy can kill difficult-to-treat infections and enhance the host’s natural immune response. Existing antibiotics…
